TECTONIC THERAPEUTIC INC (TECX) Stock Price, Quote, News and Overview
NASDAQ:TECX - Nasdaq - US8789721086 - Common Stock - Currency: USD
TECX Quote, Performance and Key Statistics
TECTONIC THERAPEUTIC INC
NASDAQ:TECX (1/30/2025, 1:47:49 PM)
50.29
+24.57 (+95.53%)
The current stock price of TECX is 50.29 USD. In the past month the price decreased by -45.31%.
TECX Latest News, Press Releases and Analysis
Top stock movements in today's session.
Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements.
There are notable gap-ups and gap-downs in today's session.
Let's have a look at what is happening on the US markets on Thursday. Below you can find the gap up and gap down stocks in today's session.
Stay updated with the stocks that are on the move in today's pre-market session.
Before the opening bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
Top movers analysis one hour before the close of the markets on 2025-01-28: top gainers and losers in today's session.
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
TECX Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 16.35 | 310.57B | ||
| AMGN | AMGEN INC | 14.83 | 153.24B | ||
| GILD | GILEAD SCIENCES INC | 21.82 | 120.47B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 868.24 | 114.03B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.07 | 75.22B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.77B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 35.70B | ||
| BNTX | BIONTECH SE-ADR | N/A | 29.62B | ||
| ONC | BEIGENE LTD-ADR | N/A | 24.30B | ||
| NTRA | NATERA INC | N/A | 23.28B | ||
| BIIB | BIOGEN INC | 9.01 | 21.44B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 16.49B |
Related stock screener links
About TECX
Company Profile
Tectonic Therapeutic Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Watertown, Massachusetts and currently employs 13 full-time employees. The company went IPO on 2018-06-21. Tectonic Therapeutic, Inc. is a biotechnology company. The firm is focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs). Leveraging its technology platform called GEODe (GPCRs Engineered for Optimal Discovery), the Company is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery and harness the human body to modify the course of disease. The Company’s lead program, TX000045 (TX45), is an Fc-relaxin fusion molecule that activates the RXFP1 receptor, the GPCR target of the hormone relaxin. TX45 is being evaluated in Phase Ia/Ib clinical trials as a potential treatment for Group 2 Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (HFpEF). Its second program addresses Hereditary Hemorrhagic Telangiectasia (HHT).
Company Info
TECTONIC THERAPEUTIC INC
490 Arsenal Way, Suite 210
Watertown MASSACHUSETTS US
Employees: 13
Company Website: https://tectonictx.com/
Investor Relations: https://investors.avrobio.com/
Phone: 13396663320
TECX FAQ
What is the stock price of TECX?
The current stock price of TECX is 50.29 USD.
What is the symbol for TECTONIC THERAPEUTIC INC stock?
The exchange symbol of TECTONIC THERAPEUTIC INC is TECX and it is listed on the Nasdaq exchange.
On which exchange is TECX stock listed?
TECX stock is listed on the Nasdaq exchange.
Is TECX a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for TECX, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of TECX.
Does TECX stock pay dividends?
TECX does not pay a dividend.
What is the Price/Earnings (PE) ratio of TECX?
TECX does not have a PE ratio as the earnings reported over the last twelve months were negative (-9.74).
What is the Short Interest ratio of TECX stock?
The outstanding short interest for TECX is 6.63% of its float.
TECX Technical Analysis
TECX Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to TECX. While TECX seems to be doing ok healthwise, there are quite some concerns on its profitability.
TECX Financial Highlights
Over the last trailing twelve months TECX reported a non-GAAP Earnings per Share(EPS) of -9.74. The EPS decreased by -399.49% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -32.24% | ||
| ROE | -36.18% | ||
| Debt/Equity | 0 |
TECX Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 84% to TECX. The Buy consensus is the average rating of analysts ratings from 10 analysts.